-
Karyopharm Therapeutics' (KPTI) "Buy" Rating Reiterated at HC Wainwright
ソース: Buzz FX / 15 1 2025 07:26:16 America/New_York
Karyopharm Therapeutics' (KPTI) "Buy" Rating Reiterated at HC Wainwright Written by MarketBeat January 15, 2025 Share Link copied to clipboard. Karyopharm Therapeutics ( NASDAQ:KPTI - Get Free Report ) 's stock had its "buy" rating reiterat
Read more...